Evolutionary life saving biomaterials

GizaVC invests in the vision of Israel's most innovative entrepreneurs.


LifeBond is developing a series of sealants and active convergence hemostats - solutions that minimize fatalities and damage from trauma wounds and surgical injuries. Unlike available biological sealants, LifeBond's adhesives are inexpensive to produce, stable, and contain only biocompatible substances.

lifebond c



Ishay Attar, Orahn Preiss-Bloom, Nir Mashkif 


CEO: Gideon Sturlesi         CTO: Orahn Preiss-Bloom

COO: Gal Eisenberg

Giza's Board Member

Yuval Avni



Fields of invesment: icon life Healthcare

Contact info: Website